A therapy in which an athlete’s own blood is injected into a wounded area could improve treatment.
Sourced through Scoop.it from: www.nytimes.com
Dr. Mishra’s Double-Blind PRP Study On Chronic Tennis Elbow
In this photo we see Dr. Allan K. Mishra, Orthopedist at Stanford University’s Menlo Clinic in Menlo Park, California, displaying a tube containing centrifuged, separated blood.
The platelets, in a thin layer in the middle, are taken along with some of that plasma, (hence, Platelet-Rich Plasma) and injected into the injured area with the hope of stimulating the healing process.
This NY Times article looks to be one of the first major news pieces on Platelet-Rich Plasma Therapy, which may have helped spawn a wave of publicity.
Dr. Mishra is credited with being one of the pioneers of this technique, which has been rapidly gaining popularity in the past 5 years or so, (likely due to it’s well-publicized adoption by many high-profile pro athletes like Tiger Woods, Maria Sharapova and Hines Ward.)
His recent study, ‘Efficacy of platelet-rich plasma for chronic Tennis Elbow: a double-blind, prospective, multicenter, randomized controlled trial of 230 patients.’ published in the American Journal of Sports Medicine in 2014:
The study concluded that:
“No significant differences were found at 12 weeks in this study. At 24 weeks, however, clinically meaningful improvements were found in patients treated with leukocyte-enriched PRP compared with an active control group.”
And for a more detailed look, including my own take on it, see my latest post on Platelet-Rich Plasma here: